ARYX
Aryx Therapeutics Inc
Biopharmaceutical company developing RetroMetabolic drugs, including naronapride (ATI-7505) for gastrointestinal motility disorders
CUSIP: 043387109HealthcareUS1 holder
Aryx Therapeutics Inc
Biopharmaceutical company developing RetroMetabolic drugs, including naronapride (ATI-7505) for gastrointestinal motility disorders
No insider transactions reported in the last 5 years. Look across all recorded history →